Send us Feedback

BSD Medical (BSM)
Analysis
SUMMARY
BULLS
BEARS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

 
Annual Reports

  • 10-K (Nov 14, 2012)
  • 10-K (Nov 14, 2011)
  • 10-K (Nov 29, 2010)
  • 10-K (Nov 6, 2009)
  • 10-K (Nov 14, 2008)
  • 10-K (Nov 14, 2007)

 
Quarterly Reports

 
8-K

 
Other

BSD MEDICAL CORP 8-K 2009

Documents found in this filing:

  1. 8-K/A
  2. Ex-99.1
  3. Ex-99.1
bsdm8ka20090727.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

FORM 8-K/A

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)July 27, 2009

BSD MEDICAL CORPORATION
(Exact name of registrant as specified in its charter)

Delaware
0-10783
75-1590407
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification)


2188 West 2200 South
Salt Lake City, Utah 84119
(Address of principal executive offices, including Zip Code)
Registrant’s telephone number, including area code:  (801) 972-5555


N/A
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
1
 

Item 7.01                      Regulation FD Disclosure.

On July 27, 2009, BSD Medical Corporation completed the mailing of a letter to shareholders dated July, 21, 2009 and signed by Harold R. Wolcott, President.  A copy of the letter to shareholders is hereby furnished as Exhibit 99.1 attached hereto and incorporated by reference herein.

Item 9.01                      Financial Statements and Exhibits.

(d)
Exhibits









SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated:  July 29, 2009
 
By:
/s/  Dennis P. Gauger
   
Dennis P. Gauger
   
Chief Financial Officer

 
2
 

EXHIBIT INDEX

 
 
 
3
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki